NCT07052123 Non-Invasive Blood Pressure Monitoring in ICU Patients Using the DARE Device
| NCT ID | NCT07052123 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier de Saint-Denis |
| Condition | Hemodynamics |
| Study Type | INTERVENTIONAL |
| Enrollment | 2 participants |
| Start Date | 2025-03-24 |
| Primary Completion | 2028-03-24 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 2 participants in total. It began in 2025-03-24 with a primary completion date of 2028-03-24.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study tests a new non-invasive device called DARE to monitor blood pressure in patients in intensive care. It compares the device's readings to standard invasive methods and also looks at how well it measures other vital signs like temperature, oxygen levels, and heart rhythm. The goal is to improve patient safety and comfort while helping doctors detect problems earlier.
Eligibility Criteria
Inclusion Criteria: * Adult patients (male or female), aged 18 years or older * Admitted to intensive care unit (ICU) or critical care with an expected hospital stay longer than 2 days * Equipped with an arterial catheter for invasive blood pressure monitoring * Equipped with a urinary catheter for invasive core body temperature monitoring Exclusion Criteria: * Patients under 18 years old (minors) * Known skin allergy to adhesives or silicone, or skin condition preventing adhesive use * History of extensive skin pathology (e.g., Lyell syndrome) * Patients with therapeutic limitations * Patients with active implanted medical devices (e.g., pacemaker, defibrillator) * Pregnant or breastfeeding women * Patients not affiliated with the French social security system * Patients or their legal representatives refusing consent, or unable to understand information and give informed consent * Patients under legal guardianship, curatorship, or deprived of liberty
Frequently Asked Questions
Who can join the NCT07052123 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hemodynamics. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07052123 currently recruiting?
Yes, NCT07052123 is actively recruiting participants. Visit ClinicalTrials.gov or contact Centre Hospitalier de Saint-Denis to inquire about joining.
Where is the NCT07052123 trial being conducted?
This trial is being conducted at Saint-Denis, France.
Who is sponsoring the NCT07052123 clinical trial?
NCT07052123 is sponsored by Centre Hospitalier de Saint-Denis. The trial plans to enroll 2 participants.